Menu
GWAS Study

Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk.

Walsh KM, Codd V, Smirnov IV et al.

24908248 PubMed ID
GWAS Study Type
9380 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

WK
Walsh KM
CV
Codd V
SI
Smirnov IV
RT
Rice T
DP
Decker PA
HH
Hansen HM
KT
Kollmeyer T
KM
Kosel ML
MA
Molinaro AM
ML
McCoy LS
BP
Bracci PM
CB
Cabriga BS
PM
Pekmezci M
ZS
Zheng S
WJ
Wiemels JL
PA
Pico AR
TT
Tihan T
BM
Berger MS
CS
Chang SM
PM
Prados MD
LD
Lachance DH
OB
O'Neill BP
SH
Sicotte H
EJ
Eckel-Passow JE
VD
van der Harst P
WJ
Wiencke JK
SN
Samani NJ
JR
Jenkins RB
WM
Wrensch MR
Chapter II

Abstract

Summary of the research findings

Glioma, the most common central nervous system cancer in adults, has poor prognosis. Here we identify a new SNP associated with glioma risk, rs1920116 (near TERC), that reached genome-wide significance (Pcombined = 8.3 × 10(-9)) in a meta-analysis of genome-wide association studies (GWAS) of high-grade glioma and replication data (1,644 cases and 7,736 controls). This region has previously been associated with mean leukocyte telomere length (LTL). We therefore examined the relationship between LTL and both this new risk locus and other previously established risk loci for glioma using data from a recent GWAS of LTL (n = 37,684 individuals). Alleles associated with glioma risk near TERC and TERT were strongly associated with longer LTL (P = 5.5 × 10(-20) and 4.4 × 10(-19), respectively). In contrast, risk-associated alleles near RTEL1 were inconsistently associated with LTL, suggesting the presence of distinct causal alleles. No other risk loci for glioma were associated with LTL. The identification of risk alleles for glioma near TERC and TERT that also associate with telomere length implicates telomerase in gliomagenesis.

1,013 European ancestry cases, 6,595 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

9380
Total Participants
GWAS
Study Type
Yes
Replicated
631 European ancestry cases, 1,141 European ancestry controls
Replication Participants
European
Ancestry
U.S., Canada
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.